Arcutis Biotherapeutics (ARQT) Inventory Average (2022 - 2026)

Arcutis Biotherapeutics' Inventory Average history runs 5 years deep, the most recent figure standing at $30.0 million for Q1 2026.

• In Q1 2026, Inventory Average rose 92.76% year-over-year to $30.0 million; the TTM figure through Mar 2026 stood at $30.0 million (up 92.76% YoY), while the FY2025 annual figure was $18.6 million, up 34.35% from the prior year.
• Inventory Average for Q1 2026 stood at $30.0 million, up from $22.5 million in the prior quarter.
• The five-year high for Inventory Average was $30.0 million in Q1 2026, with the low at $5.9 million in Q4 2022.
• The 5-year median for Inventory Average is $13.8 million (2024), against an average of $14.9 million.
• The sharpest annual moves came in 2023 and 2024: Inventory Average surged 128.8% in 2023, then advanced 5.52% in 2024.
• Arcutis Biotherapeutics' Inventory Average stood at $5.9 million in 2022, then soared by 128.8% to $13.5 million in 2023, then increased by 5.52% to $14.3 million in 2024, then surged by 57.85% to $22.5 million in 2025, then jumped by 33.23% to $30.0 million in 2026.
• Business Quant data shows ARQT's Inventory Average at $30.0 million in Q1 2026, $22.5 million in Q4 2025, and $19.4 million in Q3 2025.